Recro Pharma Inc (REPH) |
|
3.63 -0.24 (-6.2%)
|
03-05 09:18 |
|
Open: |
3.81 |
Pre. Close: |
3.87 |
|
High:
|
3.8833 |
Low:
|
3.44 |
|
Volume:
|
577,919 |
Market Cap:
|
121M |
|
|
|
|
Recro Pharma, Inc. a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products to pharmaceutical market in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was founded in 2007 and is based in Malvern, Pennsylvania. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
3.889 - 3.908 |
3.908 - 3.924 |
|
Low:
|
3.392 - 3.416 |
3.416 - 3.435 |
|
Close:
|
3.595 - 3.633 |
3.633 - 3.663 |
|
Technical analysis |
as of: 2021-03-05 8:51:39 AM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 5.17 One year: 6.18 |
| Support: |
Support1: 3.03 Support2: 2.52 |
| Resistance: |
Resistance1: 4.43 Resistance2: 5.29 |
| Pivot: |
4.35 |
| Moving Average: |
MA(5): 3.74 MA(20): 4.23
MA(100): 2.86  MA(250): 4.12 |
| MACD: |
MACD(12,26): 0.11 Signal(9): 0.25 |
| Stochastic oscillator: |
%K(14,3): 21.57 %D(3): 23.05 |
| RSI: |
RSI(14): 44.86 |
| 52-week: |
High: 9.86 Low: 1.49 Change(%): -63.1 |
| Average Vol(K): |
3-Month: 132979 10-Days: 101330 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.REPH has closed above bottom band by 13.4%. Bollinger Bands are 96.9% wider than normal. The large width of the bands suggest high volatility as compared to REPH's normal range. The bands have been in this wide range for 16 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Tue, 02 Mar 2021
Recro to Present at H.C. Wainwright Global Life Science Conference - GlobeNewswire
Sat, 27 Feb 2021
Recro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
Fri, 26 Feb 2021
Mid-day market update: Nasdaq rises over 100 points; Recro Pharma (REPH Stock) shares plummet - FXStreet
Fri, 26 Feb 2021
Analyst Rating: Will Recro Pharma Inc (REPH) Stock Beat the Market? - InvestorsObserver
Fri, 26 Feb 2021
Recro Pharma, Inc. to Host Earnings Call - Yahoo Finance
Tue, 23 Feb 2021
Recro Announces Amendment to Athyrium Credit Facility - GlobeNewswire
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Underperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Underperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Drug Manufacturers General Specialty & Generic |
| Shares Out. (M) |
24 |
| Shares Float (M) |
20 |
|
% Held by Insiders
|
2.40 |
|
% Held by Institutions
|
79.63 |
|
Shares Short (K)
|
974 |
|
Shares Short P. Month (K)
|
966 |
Stock Financials |
|
EPS
|
-1.083 |
|
EPS Est This Year
|
-2.350 |
|
EPS Est Next Year
|
-2.590 |
|
Book Value (p.s.)
|
-0.640 |
|
Profit Margin
|
-34.14 |
|
Operating Margin
|
0.74 |
|
Return on Assets (ttm)
|
0.3 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
-23.6 |
|
Gross Profit (p.s.)
|
2.041 |
|
Sales Per Share
|
3.140 |
|
EBITDA (p.s.)
|
0.391 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
15 |
|
Levered Free Cash Flow (M)
|
2 |
Stock Valuations |
|
PE Ratio
|
-3.35 |
|
PEG Ratio
|
|
|
Price to Book value
|
-5.67 |
|
Price to Sales
|
1.16 |
|
Price to Cash Flow
|
5.89 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
